Analysis of Clinical Interventions and the Impact of Pediatric Pharmacists on Medication Error Prevention in a Teaching Hospital

Abstract

OBJECTIVE Research has shown that the potential risk for medication errors within the pediatric inpatient population is about 3 times as high as for adults; however, there is limited information regarding the impact of a pediatric pharmacist's contribution to decreasing medication errors and adverse drug events (ADEs). The purpose of this study was to record and analyze all interventions during a 2-month time span in a pediatric teaching hospital to determine the benefit of having a pediatrics-trained clinical pharmacist on the floor. METHODS Pediatric pharmacists prospectively collected data for all interventions and medication errors made between July 1 and August 31, 2010. The pediatric hospital comprises 87 beds, and data were collected during the influx of new pediatric resident interns on the general pediatric ward and pediatric and neonatal intensive care units. RESULTS During the study period, 1315 interventions were recorded, which is an average of 21 interventions per day. Most interventions were made through order entry. Errors made up 24.5% of all interventions, with the most common cause of error being prescribing. Physicians with the least amount of training made the most errors. Of order pages scanned, 5.9% contained an error in the order; however, only 0.2% of all errors reached the patient. CONCLUSIONS This study highlighted the impact a pediatric pharmacist can make on prevention of ADEs and medication errors. Only 0.2% of all errors made during the study period reached the patient owing to interventions made by the pediatric pharmacists, which shows a vast improvement in patient safety.

Medication safety strategies in hospitals – A systematic review

“…Another four papers [5][6][7][8] were added from handsearching references and medication-safety-specific journals, leading to a total of 2243 papers. Abstracts (n = 84) were selected for further examination and 56 full papers were identified for additional screening.…”

Pharmacist perceptions on the need for a quality guidance resource for pharmacy service provision in the neonatal intensive care unit: comparison between Poland and Australia

“…As such, the role of the pharmacist within the specialist area of neonatology is continually advancing towards more direct involvement in patient care . Indeed, the benefits of pharmacist interventions include reduced incidence of medication errors, optimisation of total parenteral nutrition (TPN) regimens and better rationalisation of pharmacotherapy …”

“…[3] Indeed, the benefits of pharmacist interventions include reduced incidence of medication errors, optimisation of total parenteral nutrition (TPN) regimens and better rationalisation of pharmacotherapy. [4][5][6][7] It is evident that pharmacist practice varies in NICU settings both on a national scale and international scale. [8] A recent study by Krzy_ zaniak et al [9] highlighted that pharmacy services delivered to NICU settings in Poland and Australia differed significantly, with the focus of practice in each country centred on dispensary-based and clinical, ward-based services respectively.…”

Avaliação do impacto das intervenções do farmacêutico clínico na prevenção de problemas relacionados à farmacoterapia em um centro de terapia intensiva pediátrico de hospital de ensino

“…Se não houver intervenções, os PRF podem comprometer a eficácia da farmacoterapia e contribuir para o aumento da morbimortalidade, do tempo de hospitalização e da permanência em UTI, aumentando, consequentemente, os custos com a saúde (WESTERLUND;MARKLUND, 2009;DE GIORGI et al, 2010;CUNNINGHAM, 2012;MANIAS et al, 2014). A literatura recente relata que 2 a 5% de todas as admissões hospitalares sofrem de algum tipo de PRF (WESTERLUND; MARKLUND, 2009).…”

“…No Brasil a RDC 7, de 24 de fevereiro de 2010 e a portaria 930, de 10 de maio de 2012 do Ministério da Saúde, preveem como padrões mínimos para funcionamento das UTIs, dentro dos requisitos de recursos humanos, que deve ser garantido por meios próprios ou terceirizados, a assistência farmacêutica à beira leito, visando a redução de riscos e minimização de eventos adversos relacionados a medicamentos e insumos farmacêuticos (BRASIL, 2010;2012 Esse método foi desenvolvido pela NASA (National Aeronautics and Space Administration) em 1963, aproximadamente, durante a missão Apollo, e teve como objetivo identificar modos potenciais de falha em sistemas, processos ou serviços, seus fatores causais e, a partir disso, definir ações para reduzir ou eliminar o risco associado a essas falhas.…”